232 related articles for article (PubMed ID: 27199554)
1. In vitro modeling of COPD inflammation and limitation of p38 inhibitor - SB203580.
Meng A; Zhang X; Wu S; Wu M; Li J; Yan X; Kopec-Harding K; Wu J
Int J Chron Obstruct Pulmon Dis; 2016; 11():909-17. PubMed ID: 27199554
[TBL] [Abstract][Full Text] [Related]
2. Novel p38 MAPK inhibitor ML3403 has potent anti-inflammatory activity in airway smooth muscle.
Munoz L; Ramsay EE; Manetsch M; Ge Q; Peifer C; Laufer S; Ammit AJ
Eur J Pharmacol; 2010 Jun; 635(1-3):212-8. PubMed ID: 20226180
[TBL] [Abstract][Full Text] [Related]
3. Differential anti-inflammatory effects of budesonide and a p38 MAPK inhibitor AZD7624 on COPD pulmonary cells.
Higham A; Karur P; Jackson N; Cunoosamy DM; Jansson P; Singh D
Int J Chron Obstruct Pulmon Dis; 2018; 13():1279-1288. PubMed ID: 29719383
[TBL] [Abstract][Full Text] [Related]
4. Additive Suppression of LPS-Induced IL-10 and TNF-α by Pre-treatment of Dexamethasone and SB203580 in a Murine Alveolar Macrophage Cell Line (MH-S).
Meng A; Wang B; Zhang X; Qi N; Liu D; Wu J
Inflammation; 2015; 38(3):1260-6. PubMed ID: 25563207
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of p38 mitogen-activated protein kinase inhibition with a corticosteroid in alveolar macrophages from patients with chronic obstructive pulmonary disease.
Armstrong J; Harbron C; Lea S; Booth G; Cadden P; Wreggett KA; Singh D
J Pharmacol Exp Ther; 2011 Sep; 338(3):732-40. PubMed ID: 21610141
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-α and interleukin-1β expression pathway induced by Streptococcus mutans in macrophage cell line RAW 264.7.
Kim JS; Kim KD; Na HS; Jeong SY; Park HR; Kim S; Chung J
Mol Oral Microbiol; 2012 Jun; 27(3):149-59. PubMed ID: 22520385
[TBL] [Abstract][Full Text] [Related]
7. p38 MAPK inhibition in nucleus pulposus cells: a potential target for treating intervertebral disc degeneration.
Studer RK; Aboka AM; Gilbertson LG; Georgescu H; Sowa G; Vo N; Kang JD
Spine (Phila Pa 1976); 2007 Dec; 32(25):2827-33. PubMed ID: 18246004
[TBL] [Abstract][Full Text] [Related]
8. Reversal of corticosteroid insensitivity by p38 MAPK inhibition in peripheral blood mononuclear cells from COPD.
Khorasani N; Baker J; Johnson M; Chung KF; Bhavsar PK
Int J Chron Obstruct Pulmon Dis; 2015; 10():283-91. PubMed ID: 25678784
[TBL] [Abstract][Full Text] [Related]
9. Intracisternal administration of SB203580, a p38 mitogen-activated protein kinase inhibitor, attenuates cerebral vasospasm via inhibition of tumor-necrosis factor-α.
Pan YX; Chen KF; Lin YX; Wu W; Zhou XM; Zhang XS; Zhang X; Shi JX
J Clin Neurosci; 2013 May; 20(5):726-30. PubMed ID: 23540891
[TBL] [Abstract][Full Text] [Related]
10. SB203580, a p38 mitogen-activated protein kinase inhibitor, suppresses the development of endometriosis by down-regulating proinflammatory cytokines and proteolytic factors in a mouse model.
Zhou WD; Yang HM; Wang Q; Su DY; Liu FA; Zhao M; Chen QH; Chen QX
Hum Reprod; 2010 Dec; 25(12):3110-6. PubMed ID: 20956267
[TBL] [Abstract][Full Text] [Related]
11. The p38 MAPK inhibitor JLU1124 inhibits the inflammatory response induced by lipopolysaccharide through the MAPK-NF-κB pathway in RAW264.7 macrophages.
Li XN; Su J; Zhao L; Xiang JB; Wang W; Liu F; Li HY; Zhong JT; Bai X; Sun LK
Int Immunopharmacol; 2013 Nov; 17(3):785-92. PubMed ID: 24070708
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK.
Feng YJ; Li YY; Lin XH; Li K; Cao MH
World J Gastroenterol; 2016 Nov; 22(43):9515-9524. PubMed ID: 27920472
[TBL] [Abstract][Full Text] [Related]
13. A supercritical CO₂ extract from seabuckthorn leaves inhibits pro-inflammatory mediators via inhibition of mitogen activated protein kinase p38 and transcription factor nuclear factor-κB.
Jayashankar B; Mishra KP; Kumar MS; Udayasankar K; Misra K; Ganju L; Singh SB
Int Immunopharmacol; 2012 Aug; 13(4):461-7. PubMed ID: 22664145
[TBL] [Abstract][Full Text] [Related]
14. P38 mitogen-activated protein kinase inhibition attenuates pulmonary inflammatory response in a rat cardiopulmonary bypass model.
Dong X; Liu Y; Du M; Wang Q; Yu CT; Fan X
Eur J Cardiothorac Surg; 2006 Jul; 30(1):77-84. PubMed ID: 16723252
[TBL] [Abstract][Full Text] [Related]
15. Interleukin (IL)-17 enhances tumor necrosis factor-alpha-stimulated IL-6 synthesis via p38 mitogen-activated protein kinase in osteoblasts.
Tokuda H; Kanno Y; Ishisaki A; Takenaka M; Harada A; Kozawa O
J Cell Biochem; 2004 Apr; 91(5):1053-61. PubMed ID: 15034939
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroid effects on COPD alveolar macrophages: dependency on cell culture methodology.
Higham A; Lea S; Ray D; Singh D
J Immunol Methods; 2014 Mar; 405(100):144-53. PubMed ID: 24530567
[TBL] [Abstract][Full Text] [Related]
17. p38MAPK inhibition attenuates LPS-induced acute lung injury involvement of NF-kappaB pathway.
Liu S; Feng G; Wang GL; Liu GJ
Eur J Pharmacol; 2008 Apr; 584(1):159-65. PubMed ID: 18328478
[TBL] [Abstract][Full Text] [Related]
18. A randomized, placebo-controlled study of the effects of the p38 MAPK inhibitor SB-681323 on blood biomarkers of inflammation in COPD patients.
Singh D; Smyth L; Borrill Z; Sweeney L; Tal-Singer R
J Clin Pharmacol; 2010 Jan; 50(1):94-100. PubMed ID: 19880675
[TBL] [Abstract][Full Text] [Related]
19. Icariin inhibits TNF-α/IFN-γ induced inflammatory response via inhibition of the substance P and p38-MAPK signaling pathway in human keratinocytes.
Kong L; Liu J; Wang J; Luo Q; Zhang H; Liu B; Xu F; Pang Q; Liu Y; Dong J
Int Immunopharmacol; 2015 Dec; 29(2):401-407. PubMed ID: 26507164
[TBL] [Abstract][Full Text] [Related]
20. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.
Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
Immunol Lett; 2018 Apr; 196():1-10. PubMed ID: 29329680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
